Peripheral arterial disease enters the biomarker era. Does risk stratification tell us something that we don't already know?
This editorial refers to Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease by G. Brevetti et al., on page 224.